Kleiner Perkins Caufield & Byers

RiverVest finds success in blowing the dust off old compounds

Niall O’Donnell fancies himself an archaeologist of the pharmaceutical persuasion. His firm, RiverVest Ventures, is scoping out the failed and forgotten drugs of big pharma, building companies to repurpose these benched meds for new indications. The aim is to find drugs that have passed for safety in clinical trials, but may have shown limited efficacy […]

Ignoring these fundamentals could make it hard to scale a digital health startup

Digital health is a popular business these days, but it’s also a tricky one. In theory, remote monitoring and engagement products have the potential to drive long-term cost savings, but robust data is lacking and consumer adoption so far has been relatively low. In a guest article for Re/code, Dr. Beth Seidenberg, former chief medical […]

Devices & Diagnostics

These are the most active VCs in healthcare since 2012

As investments in life science companies have dipped over the past few years, some investors have scaled back investments or walked away from the sector all together. But based on a tally by investment research firm PitchBook in its 2013 Venture Capital Healthcare Report, several firms have made 10 or more investments in pharmaceutical, medical […]

Devices & Diagnostics

Life sciences investment shifting to Europe, Asia

Venture capital investment in the life sciences has fallen 39 percent over the past three years as the costly, lengthy process of getting  approval for pharmaceuticals from the Food and Drug Administration has spurred companies to shift their investments to overseas markets in Europe and Asia. According to the survey of 150 venture capital firms,  […]